Temperature Controlled Material Developed for Robotic Gripper Applications
When the SMP is in a soft state, it allows the gripper to make good contact with the object and conform to objects with irregular shapes or surfaces.
Penn Engineering Researchers Invent Origami-Inspired Microbots
The goal of this innovative technology is to use the microrobots to assist in repairing peripheral nerves.
Long-term Penn Research Across Disciplines Leads to the Development of a New ‘Patch’ that Uses Natural Body Motion to Fix Disc Herniation
A new biologic “patch” that is activated by a person’s natural motion has the potential to fix herniated discs in people’s backs, according to researchers at Penn Medicine and the CMC VA Medical Cente
Mitchell Lab: Lipid nanoparticles that deliver mRNA to T cells show potential treatment for autoimmune diseases
The goal of this platform is to engineer adoptive cell therapies inside of the body for specific autoimmune diseases.
Penn Faculty Discover An Innovative Potential Treatment for Tooth Decay
In search of a more effective treatment, the research team employed a combination of ferumoxytol (Fer) and stannous fluoride (SnF2) to fight tooth decay.
Penn biomedical scientists move into new uCity complex with 115,000 square feet of lab space
A group of Penn scientists and engineers is moving into 115,000 square feet of new lab space in the 13-story One uCity Square building in West Philadelphia.
Team members of I Corps Team and Penn President’s Prize Winner Sonura are Named Philadelphia Business Journal’s “Inno Under 25”
The group was named as 2023’s Inno Under 25 honorees by the Philadelphia Business Journal.
Mitchell Named “Young Innovator of Cellular and Molecular Bioengineering”
Mike Mitchell, PhD, J. Peter and Geri Skirkanich Assistant Professor of Innovation in Bioengineering (BE), was named a "Young Innovator of Cellular and Molecular Bioengineering."
Lipid Nanoparticles Speed up CAR T Cell Manufacturing
The new method involves attaching a sugar molecule onto the surface of CAR T cells using metabolic labeling, a modification that enables the CAR T cells to attack cancer cells without any hindrance.
Mitchell Lab develops a microchip designed to transform the production of mRNA therapeutics and vaccines
“This technology has the potential to become a cornerstone in the field of nanomedicine, beyond RNA-based therapies,” Mitchell said in the Penn Today article.